Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Substituted benzopyrans as selective estrogen receptor-beta agonists

Substituted benzopyrans as selective estrogen receptor-beta agonists

US Patent 7585985 · Granted Sep 8, 2009

Estimated economic value: $83,913,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compounds useful for inhibiting RORγt2021
Compounds useful for inhibiting ROR-gamma-t2020
Dihydropyrido pyrimidine compounds as autotaxin inhibitors2017
Dihydropyrido pyrimidine compounds as autotaxin inhibitors2017
Imidazo pyridine compounds2016
Imidazo pyridine compounds2016
Phenyl methanesulfonamide derivatives useful as MGAT-2 inhibitors2015
Bicyclic pyrimidine compounds2015
Bicyclic pyrimidine compounds2015
Imidazole derivatives useful for the treatment of arthritis2014
Benzyl sulfonamide derivatives useful as MOGAT-2 inhibitors2013
Selective estrogen receptor modulator for the treatment of osteoarthritis2013